Chi Sheng Pharma & Biotech Co., Ltd 4111.TWO Stock
Chi Sheng Pharma & Biotech Co., Ltd Price Chart
Chi Sheng Pharma & Biotech Co., Ltd 4111.TWO Financial and Trading Overview
| Chi Sheng Pharma & Biotech Co., Ltd stock price | 28.95 TWD |
| Previous Close | 28.75 TWD |
| Open | 28.8 TWD |
| Bid | 28.9 TWD x 0 |
| Ask | 28.95 TWD x 0 |
| Day's Range | 28.75 - 29.1 TWD |
| 52 Week Range | 22.55 - 36.85 TWD |
| Volume | 336.02K TWD |
| Avg. Volume | 1.19M TWD |
| Market Cap | 1.65B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 10.087109 |
| EPS (TTM) | 2.02 TWD |
| Forward Dividend & Yield | 1 (3.45%) |
| Ex-Dividend Date | August 22, 2022 |
| 1y Target Est | N/A |
4111.TWO Valuation Measures
| Enterprise Value | 1.27B TWD |
| Trailing P/E | 10.087109 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4593925 |
| Price/Book (mrq) | 1.3234286 |
| Enterprise Value/Revenue | 1.12 |
| Enterprise Value/EBITDA | 6.391 |
Trading Information
Chi Sheng Pharma & Biotech Co., Ltd Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 23.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 36.85 TWD |
| 52 Week Low | 22.55 TWD |
| 50-Day Moving Average | 30.04 TWD |
| 200-Day Moving Average | 26.81 TWD |
4111.TWO Share Statistics
| Avg. Volume (3 month) | 1.19M TWD |
| Avg. Daily Volume (10-Days) | 419.1K TWD |
| Shares Outstanding | 56.98M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 25.88% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.2 |
| Trailing Annual Dividend Yield | 4.17% |
| 5 Year Average Dividend Yield | 356.00% |
| Payout Ratio | 0.3484 |
| Last Split Factor | 1040:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.97% |
| Operating Margin (ttm) | 12.05% |
| Gross Margin | 36.25% |
| EBITDA Margin | 17.52% |
Management Effectiveness
| Return on Assets (ttm) | 4.99% |
| Return on Equity (ttm) | 13.83% |
Income Statement
| Revenue (ttm) | 1.13B TWD |
| Revenue Per Share (ttm) | 19.84 TWD |
| Quarterly Revenue Growth (yoy) | -6.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | 198.1M TWD |
| Net Income Avi to Common (ttm) | 164.32M TWD |
| Diluted EPS (ttm) | 2.87 |
| Quarterly Earnings Growth (yoy) | -28.29% |
Balance Sheet
| Total Cash (mrq) | 440.25M TWD |
| Total Cash Per Share (mrq) | 7.76 TWD |
| Total Debt (mrq) | 66.9M TWD |
| Total Debt/Equity (mrq) | 5.39 TWD |
| Current Ratio (mrq) | 1.987 |
| Book Value Per Share (mrq) | 21.875 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 225.14M TWD |
| Levered Free Cash Flow (ttm) | 107.8M TWD |
Profile of Chi Sheng Pharma & Biotech Co., Ltd
| Country | Taiwan |
| State | N/A |
| City | Hsinchu City |
| Address | No. 3, Shih Chen Road |
| ZIP | 30352 |
| Phone | 886 3 598 3811 |
| Website | https://www.cscp.com.tw |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Chi Sheng Pharma & Biotech Co., Ltd manufactures and distributes medical medicines and equipment in Taiwan and internationally. Its products include antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerves agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and anti-asthmas; gastro-intestinal preparations; local anesthetic preparations; hemodialysis concentrate and external solutions; peritoneal dialysis solutions; and others. The company also offers medical devices, fat emulsion products, anesthetic products, hemostatics solutions, food products, health foods, functional drinks, skin care products, cosmetics, and veterinary medicinal products. In addition, it offers externally applied medicines, including contact lens, salt, and iodine solutions. Chi Sheng Pharma & Biotech Co., Ltd was founded in 1962 and is headquartered in Hsin Chu, Taiwan.
Q&A For Chi Sheng Pharma & Biotech Co., Ltd Stock
What is a current 4111.TWO stock price?
Chi Sheng Pharma & Biotech Co., Ltd 4111.TWO stock price today per share is 28.95 TWD.
How to purchase Chi Sheng Pharma & Biotech Co., Ltd stock?
You can buy 4111.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Chi Sheng Pharma & Biotech Co., Ltd?
The stock symbol or ticker of Chi Sheng Pharma & Biotech Co., Ltd is 4111.TWO.
Which industry does the Chi Sheng Pharma & Biotech Co., Ltd company belong to?
The Chi Sheng Pharma & Biotech Co., Ltd industry is Medical Instruments & Supplies.
How many shares does Chi Sheng Pharma & Biotech Co., Ltd have in circulation?
The max supply of Chi Sheng Pharma & Biotech Co., Ltd shares is 56.98M.
What is Chi Sheng Pharma & Biotech Co., Ltd Price to Earnings Ratio (PE Ratio)?
Chi Sheng Pharma & Biotech Co., Ltd PE Ratio is 14.33168400 now.
What was Chi Sheng Pharma & Biotech Co., Ltd earnings per share over the trailing 12 months (TTM)?
Chi Sheng Pharma & Biotech Co., Ltd EPS is 2.02 TWD over the trailing 12 months.
Which sector does the Chi Sheng Pharma & Biotech Co., Ltd company belong to?
The Chi Sheng Pharma & Biotech Co., Ltd sector is Healthcare.